TY - JOUR
T1 - Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease
T2 - prognosis prediction and mutual agreement
AU - Hyun, Hye Kyung
AU - Yu, Jongwook
AU - Kang, Eun Ae
AU - Park, Jihye
AU - Park, Soo Jung
AU - Park, Jae Jun
AU - Kim, Tae Il
AU - Kim, Won Ho
AU - Cheon, Jae Hee
N1 - Publisher Copyright:
© 2022 The Korean Association of Internal Medicine.
PY - 2022
Y1 - 2022
N2 - Background/Aims: The optimal tools for monitoring Crohn’s disease (CD) are controversial. We compared radiology plus ileocolonoscopy and radiology alone in terms of prognosis prediction and evaluated the agreement between radiologic and ileocolonoscopic findings in patients with CD. Methods: Patients with CD who were followed up with computed tomography enterography (CTE) or magnetic resonance enterography (MRE) alone or CTE or MRE plus ileocolonoscopy were retrospectively recruited. Time to relapse was investigat-ed to evaluate the difference in prognosis using the log-rank and Cox regression tests, and the agreement between radiologic and ileocolonoscopic findings was determined using a kappa value. Results: A total of 501 patients with CD in clinical remission who underwent CTE or MRE and/or ileocolonoscopy were analyzed. Of these, 372 (74.3%) patients underwent CTE or MRE alone and 129 (25.7%) patients underwent CTE or MRE plus ileocolonoscopy. The cumulative maintenance rate of clinical remission between the two groups was not significantly different (p = 0.526, log-rank test). In multivariate analysis, age <40 years (hazard ratio [HR], 2.756; 95% confidence interval [CI], 1.263 to 6.013) and a history of steroid use (HR, 2.212; 95% CI, 1.258 to 3.577) were found to independently predict an increased risk for clinical relapse in patients with CD in clinical remission. Radiologic and ileocolonoscopic findings had a moderate degree of agreement (κ = 0.401, –0.094 to 0.142). The comparison of agreement between radiologic and ileoco-lonoscopic findings was the highest in the anastomotic site (κ = 0.749, –0.168 to 0.377). Conclusions: Radiology plus ileocolonoscopy was not superior to radiology alone in predicting the prognosis of CD.
AB - Background/Aims: The optimal tools for monitoring Crohn’s disease (CD) are controversial. We compared radiology plus ileocolonoscopy and radiology alone in terms of prognosis prediction and evaluated the agreement between radiologic and ileocolonoscopic findings in patients with CD. Methods: Patients with CD who were followed up with computed tomography enterography (CTE) or magnetic resonance enterography (MRE) alone or CTE or MRE plus ileocolonoscopy were retrospectively recruited. Time to relapse was investigat-ed to evaluate the difference in prognosis using the log-rank and Cox regression tests, and the agreement between radiologic and ileocolonoscopic findings was determined using a kappa value. Results: A total of 501 patients with CD in clinical remission who underwent CTE or MRE and/or ileocolonoscopy were analyzed. Of these, 372 (74.3%) patients underwent CTE or MRE alone and 129 (25.7%) patients underwent CTE or MRE plus ileocolonoscopy. The cumulative maintenance rate of clinical remission between the two groups was not significantly different (p = 0.526, log-rank test). In multivariate analysis, age <40 years (hazard ratio [HR], 2.756; 95% confidence interval [CI], 1.263 to 6.013) and a history of steroid use (HR, 2.212; 95% CI, 1.258 to 3.577) were found to independently predict an increased risk for clinical relapse in patients with CD in clinical remission. Radiologic and ileocolonoscopic findings had a moderate degree of agreement (κ = 0.401, –0.094 to 0.142). The comparison of agreement between radiologic and ileoco-lonoscopic findings was the highest in the anastomotic site (κ = 0.749, –0.168 to 0.377). Conclusions: Radiology plus ileocolonoscopy was not superior to radiology alone in predicting the prognosis of CD.
UR - http://www.scopus.com/inward/record.url?scp=85129996658&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129996658&partnerID=8YFLogxK
U2 - 10.3904/kjim.2021.233
DO - 10.3904/kjim.2021.233
M3 - Article
C2 - 34695881
AN - SCOPUS:85129996658
SN - 1226-3303
VL - 37
SP - 567
EP - 578
JO - Korean Journal of Internal Medicine
JF - Korean Journal of Internal Medicine
IS - 3
ER -